-The Times of India BHOPAL: More than Rs 35,000 crore of stashed cash was pulled out of hidden lockers of corporates and individuals and deposited in 25 major banks within 60 days of demonetisation in Madhya Pradesh, reveal documents accessed by TOI. More than 40% of these accounts are under I-T surveillance, say sources. Money in Pradhan Mantri Jan Dhan Yojana accounts rose by Rs 461 crore after the note ban —...

-Livemint.com Aadhaar’s designers promised a robust privacy legislation, but the current government’s stance is that Indians have no fundamental right to privacy To govern India is to be constantly overwhelmed. So much needs to be done, and there’s so little to do it with. It’s hardly surprising that the Indian state is rarely ambitious. It seeks to manage, not to transform. One recent government initiative, less than a decade old, is by contrast...

-PTI New Delhi: A Rs. 48,000-crore Budget for the national capital was presented today by the AAP Government, laying major focus on improving transport, health, water distribution and education infrastructure. In its third Budget, the Arvind Kejriwal Government abolished the Plan and non-Plan expenditure heads and presented it in terms of revenue and capital classification in line with the Centre’s decision. There was no proposal on levying any new tax. 'Outcome budget' In a first,...

-The Hindu Rise in cancer cases in Punjab can be attributed to indiscriminate use of agro-chemicals after the Green Revolution Bathinda: Lying on a bench at the Bathinda railway station, sexagenarian Gurjant Singh waits to board the Abohar-Jodhpur passenger train. He, however, is not the only one waiting. As the train chugs into the platform, people rush to claim their seats. Those who are unsuccessful settle down on the floor. Soon, the...

-The Hindu In 2014, an Indian pharmaceutical company was globally the first to receive approval to market a biosimilar, thereby affordable version, of the breast cancer drug Trastuzumab. Almost immediately, Swiss pharmaceutical company Roche, innovator of the drug, filed a suit against the Indian Food & Drug Administration (FDA) to block its sale. The action firmly put their profits ahead of the lives of women with breast cancer. Roche effectively embroiled India’s...